Ramucirumab for gastric cancer.


In recent years, various molecular target agents have been investigated for gastric cancer. VEGF is one of the most potent angiogenic factors and is a signaling molecule secreted by many solid tumors. High VEGF expression is one of the characteristic features of gastric carcinomas, thus targeting VEGF is considered a promising strategy for gastric cancer… (More)
DOI: 10.1586/17474124.2015.987754

3 Figures and Tables


  • Presentations referencing similar topics